Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Nowadays, general anaesthesia is carried under "balanced anesthesia technique" in which many anesthetic adjuvants are used simultaneously, including opioid analgesics in order to reduce the amount of inhalation agents. The most popular adjuvants used are remifentanil, which is an opioid analgesic, and dexmedetomidine. Both of these agents are short acting, can be infused with targeted concentrations, excreted shortly from the body with stable hemodynamics.
Remifentanil, when infused for more than 2 hours, causes hyperalgesia to increase the amount of pain postoperatively as well as the amount of opioid analgesics. However, dexmedetomidine does not cause hyperalgesia and is known to have an opioid -sparing effect. In our center.
In this study, we aim to compare the effects of remifentanil and dexmedetomidine on postoperative pain in patients undergoing Nuss procedure, which is a very painful operation on the chest wall.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Remifentanil group | Sham Comparator | In both interventional groups, Sevoflurane is used as an inhalational agent, in 0.5-1.5% age-adjusted Minimal Alveolar Concentration (MAC). As explained above, remifentanil is infused with Target Controlled Infusion pump, and concentration is adjusted so that Bispectral index (BIS) is maintained as 40-60, which means that the patients are maintained in general anesthesia. Remifentanil is usually infused with the effect site concentration of 2.0 to 6.0 ng/ml during general anesthesia. If bradycardia or hypotension develops due to remifentanil infusion, the infusion rate could be reduced, or inotropic, vasopressor, anticholinergic agents can be used (ephedrine, atropine, etc.) to correct the side effects of the drug, or the drug infusion can even be ceased. At the end of the surgery when skin closure starts, remifentanil infusion will be stopped. |
|
| Dexmedetomidine group | Active Comparator | In both interventional groups, Sevoflurane is used as an inhalational agent, in 0.5-1.5% age-adjusted MAC (Minimal Alveolar Concentration). As explained above, dexmedetomidine is infused with syringe pump, and concentration is adjusted so that Bispectral index (BIS) is maintained as 40-60, which means that the patients are maintained in general anesthesia. Dexmedetomidine is loaded for 10 minutes in 1mcg/kg, and then infusion rate is set between 0.4 to 0.6mcg/kg/hour for this study. If bradycardia or hypotension develops due to remifentanil infusion, the infusion rate could be reduced, or inotropic, vasopressor, anticholinergic agents can be used (ephedrine, atropine, etc.) to correct the side effects of the drug, or the drug infusion can even be ceased. At the end of the surgery when skin closure starts, dexmedetomidine infusion will be stopped. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Dexmedetomidine | Drug | Comparing effects of remifentanil versus dexmedetomidine |
|
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analogue Scale | Pain scale ranges from 0 to 10. 0 means no pain at all, and 10 being the most severe pain anyone can imagine. | Between 1~6 hours postoperatively. |
| Visual Analogue Scale | Pain scale ranges from 0 to 10. 0 means no pain at all, and 10 being the most severe pain anyone can imagine. | Between 6~12 hours postoperatively. |
| Visual Analogue Scale | Pain scale ranges from 0 to 10. 0 means no pain at all, and 10 being the most severe pain anyone can imagine. | Between 12~24 hours postoperatively. |
| Visual Analogue Scale | Pain scale ranges from 0 to 10. 0 means no pain at all, and 10 being the most severe pain anyone can imagine. | Between 24~48 hours postoperatively. |
| Measure | Description | Time Frame |
|---|---|---|
| Amount of postoperative intravenous patient controlled analgesics (PCA) used | At 60 minutes after the end of surgery | |
| Amount of fentanyl used postoperatively at the recovery unit | Amount in micgrograms per wegith in kilograms (migrogram/kilogram) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jung Min Koo, M.D | Data recruitment | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jung Min Koo | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005660 | Funnel Chest |
| ID | Term |
|---|---|
| D001848 | Bone Diseases, Developmental |
| D001847 | Bone Diseases |
| D009140 | Musculoskeletal Diseases |
| D009139 | Musculoskeletal Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D020927 | Dexmedetomidine |
| D000077208 | Remifentanil |
| ID | Term |
|---|---|
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| At 60 minutes after the end of surgery |
| Time needed for postoperative rescue opioid analgesics | At 60 minutes after the end of surgery |
| Amount of remifentanil or dexmedetomidine used intraoperatively | Immediately at the end of the surgery |
| Intraoperative hemodynamic change: Systolic blood pressure | 1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room |
| Intraoperative hemodynamic change: Diastolic blood pressure | 1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room |
| Intraoperative hemodynamic change: mean blood pressure | 1 minute after monitoring (of blood pressure, heart rate, pulse oxymeter and electrocardiogram) starts, when the patient arrives at the operating room |
| Intraoperative hemodynamic change: heart rate | 30 minutes after the induction of anesthesia |
| Intraoperative hemodynamic change: mean blood pressure | At the end of the surgery, average of 90minutes after the induction of anesthesia |
| Intraoperative hemodynamic change: heart rate | At the end of the surgery, average of 90minutes after the induction of anesthesia |
| Intraoperative hemodynamic change: Systolic blood pressure | At the end of the surgery, average of 90minutes after the induction of anesthesia |
| Intraoperative hemodynamic change: Diastolic blood pressure | At the end of the surgery, average of 90minutes after the induction of anesthesia |
| Rescue drugs (inotropics or vasopressors) used in order to correct hypotension or bradycardia | Intraoperatively |
| Postoperative complications | Number of events that happened to the patient: e.g. Yes or No, and how many times. Nausea/vomiting, hypotension, respiratory depression, urinary retension, dizziness, transient cease in use of intravenous patient controlled analgesics (PCA) | Between 1~6 hours postoperatively |
| Postoperative complications | Number of events that happened to the patient: e.g. Yes or No, and how many times. Nausea/vomiting, hypotension, respiratory depression, urinary retension, dizziness, transient cease in use of intravenous patient controlled analgesics (PCA) | Between 12~24 hours postoperatively |
| Postoperative complications | Number of events that happened to the patient: e.g. Yes or No, and how many times. Nausea/vomiting, hypotension, respiratory depression, urinary retension, dizziness, transient cease in use of intravenous patient controlled analgesics (PCA) | Between 24~48 hours postoperatively |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D011422 |
| Propionates |
| D000144 | Acids, Acyclic |
| D002264 | Carboxylic Acids |
| D009930 | Organic Chemicals |
| D010880 | Piperidines |